|
||||||||||||
![]() |
|
|||||||||||
Latest on Twitter
Daily News Wire
|
Preserving Private Medicare ChoicesCongress needs to ensure that all Americans, including Medicare beneficiaries, have a wide range of health plan choices available to them and ensure they are able to pick the policies that best suit their individual needs. Congress should not limit the ability of seniors to access any private Medicare coverage option, including Medicare Advantage plans, or the services of licensed professional health insurance producers.NAHU Issue Summary on Medicare Advantage and Selling Private Medicare ProductsThis paper outlines NAHU's key talking points as to why American seniors deserve a wide variety of private health plan options.The Coalition for Medicare ChoicesNAHU is working in conjunction with many coalition partners to preserve access to private Medicare products. Visit our coalition site to share your story about how private Medicare plans have served you and/or your clients. Click here to learn more.Selling to SeniorsNAHU’s suggestions for improved oversight and accountability in the area of Medicare insurance product marketing and sales.NAHU Overview of the New Medicare Advantage Marketing RegulationsThis document provides an overview of the new Medicare Advantage marketing rules released in the fall of 2008 and describes how they will impact NAHU members selling private Medicare Products.Comments on the Medicare Marketing Legislation and RegulationsNAHU submitted numerous comment letters to both Congress and CMS as new marketing requirements were developed relative to Medicare Advantage and Medicare Prescription Drug Plans in 2008. Comments on the Proposed Rule on Policy and Technical Changes to The Medicare Advantage and Medicare Prescription Drug Programs Comments on the Proposed Medicare Enrollment Assistance Demonstration Project Letter to Senate Finance Committee, June 2008. Comments to CMS on the proposed rule Revisions to the Medicare Advantage and Prescription Drug Benefit Programs, July 2008. Comments to CMS on the interim final rule Revisions to the Medicare Advantage and Prescription Drug Benefit Programs: Clarification of Compensation Plans, December 2008.
|
|||||||||||